Molecular Imaging and Radionuclide Therapy

Aims & Scope

Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.1
2024	0.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.275

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	15

Journal Rank

Year	Value
2024	17513

Journal Citation Indicator

Year	Value
2024	106

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Evaluation of Awareness on Radiation Protection and Knowledge About Radiological Examinations in Healthcare Professionals Who Use Ionized Radiation at Work

  Citation: 72

  Authors: Ayşegül, Berrin, Türkan

• Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry

  Citation: 68

  Authors: Levent, Türkay, Nami, Emre, Mohammad, Meltem, Aslan, Emre, Hüseyin, Nalan

• Limits of Tumor Detectability in Nuclear Medicine and PET

  Citation: 68

  Authors: ...

• I-124 Imaging and Dosimetry

  Citation: 41

  Authors: Russ, Manuel, Seza

• Molecular Profiling of Thyroid Nodules: Current Role for the Afirma Gene Expression Classifier on Clinical Decision Making

  Citation: 38

  Authors: Richard T.

• Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT

  Citation: 36

  Authors: ...

• Is Ethics Approval Necessary for all Trials? A Clear But Not Certain Process

  Citation: 34

  Authors: F. Suna

• The Value of Somatostatin Receptor Imaging with In-111 Octreotide and/or Ga-68 DOTATATE in Localizing Ectopic ACTH Producing Tumors

  Citation: 31

  Authors: Zeynep, Serkan, Deniz, Berker, Nihat

• The Diagnostic Role of FDG PET/CT in Patients with Fever of Unknown Origin

  Citation: 29

  Authors: Nurhan, Metin, Tevfik F., Resat, Sait, Çetin, Ilhami

• The Correlation of Clinicopathological Findings and Neutrophil-to- Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma

  Citation: 29

  Authors: YeÅŸim, Kamil, Aylin, YeÅŸim, Zehra

---